Skip to content

BIOMOLECULAR LIFE HOLDINGS, INC.

BIOM · OTCM

CIK 1091326fmd_027YZZEPMG7D4SFB7A7D433NHDManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2015, 9 periods

Income Statement · Annual · Millions · USD
Line itemFY2013FY2014
Total revenues00
Research and development11
Operating income(4)(4)
Interest expense13
Interest and investment income00
Other non-operating income (expense)(4)(2)
Income tax expense00
Net income(7)(6)
BIOMOLECULAR LIFE HOLDINGS, INC. (BIOM) financial statements · FinancialMD